Aditum Bio
Simon Wong has a strong background in the pharmaceutical industry, with a focus on nonclinical development and clinical pharmacology. Simon is currently serving as the Vice President of Nonclinical Development and Clinical Pharmacology at Aditum Bio since March 2023. Prior to that, Simon worked at Pliant Therapeutics, where they held various positions, including Senior Director from February 2022 to December 2022, Director from July 2020 to February 2022, and Associate Director from April 2019 to July 2020. Before joining Pliant Therapeutics, they worked at Genentech as a Senior Scientist from December 2015 to March 2019. Simon also has experience at Amgen, where they served as a Senior Scientist from September 2003 to December 2015, and at Sugen Inc as a Scientist from January 2001 to September 2003.
Simon Wong received a Bachelor of Science (BSc) degree in Life Sciences from Queen's University. Simon also obtained a Doctor of Philosophy (PhD) degree in Pharmacology and Toxicology from Queen's University as well. However, no specific start or end years were provided for their education.
Aditum Bio
Aditum Bio is an investment fund that specializes in acquiring and developing pharmaceutical assets. It gives patients access to medicines that may not otherwise be developed. Aditum Bio was founded on 2019 and is headquartered in San Francisco, California.